CHRISTOPHER REHLER: Open Payments
NPI 1285399451 · CHANUTE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 17 payments from 13 companies in 2025. Trend: 2023 $720 · 2024 $119 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| UROGEN PHARMA, INC. | 3 | $67 |
| SHIELD THERAPEUTICS INC | 1 | $49 |
| PFIZER INC. | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| ABBVIE INC. | 1 | $16 |
| Olympus America Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
Products named: ACCRUFER, JELMYTO, XTANDI, ZUSDURI, FARXIGA, ORGOVYX, BEXSERO, JOURNAVX.
Industry payments across KS — which companies pay providers there.
